WashU Medicine Knight ADRC

WashU Medicine Knight ADRC HIPAA Notice: https://bit.ly/3fWGaGX | Privacy Policy: https://bit.ly/3NUrlRK

The Washington University Knight ADRC is one of around 30 centers funded or otherwise supported by the National Institute on Aging with the collective aim of facilitating advanced research on Alzheimer Disease.

Alzheimer’s: this hidden nighttime disruption begins long before memory loss -
01/11/2026

Alzheimer’s: this hidden nighttime disruption begins long before memory loss -

What if Alzheimer’s didn’t just erase memories — but also broke the brain’s sense of time? A team of American scientists has discovered that the disease throws off the brain’s internal clock, disrupting the rhythm ... Read more

Johns Hopkins Scientists Identify Key Brain Protein That May Slow Alzheimer’s -
01/10/2026

Johns Hopkins Scientists Identify Key Brain Protein That May Slow Alzheimer’s -

Researchers have identified a brain protein whose absence leads to memory loss and Alzheimer’s-like damage in mice. Researchers at Johns Hopkins Medicine report that findings from a new study funded by the National Institutes of Health are helping to identify a promising new biological target for ...

Alzheimer's Risk May Be Driven by a Single Gene -
01/10/2026

Alzheimer's Risk May Be Driven by a Single Gene -

APOE's contribution to disease burden has been 'long underestimated,' researcher says

VA Research Wrap Up: New findings on Alzheimer’s disease, aging and pancreatic cancer -
01/10/2026

VA Research Wrap Up: New findings on Alzheimer’s disease, aging and pancreatic cancer -

VA Research recently published findings on Alzheimer's disease, returning Veterans to home after nursing care, and pancreatic cancer.

Advances in treatment in the fight against Alzheimer's disease
12/29/2025

Advances in treatment in the fight against Alzheimer's disease

The number of Americans with Alzheimer's disease is expected to double from 7 million in 2020 to 14 million by 2060, according to the CDC. However, advances ...

Amyloid Immunotherapy Affects Multiple Alzheimer’s Pathologies | ALZFORUM
12/19/2025

Amyloid Immunotherapy Affects Multiple Alzheimer’s Pathologies | ALZFORUM

Amyloid Immunotherapy Affects Multiple Alzheimer’s Pathologies Go to another part Series - Clinical Trials on Alzheimer's Disease (CTAD) 2025: Quick Links Article Comments References Further Reading Tools Add to my Library Follow News Comments Share How would you like to share? Facebook X LinkedIn...

Experimental Drug Halts Alzheimer’s Before Symptoms Begin in Mice
12/19/2025

Experimental Drug Halts Alzheimer’s Before Symptoms Begin in Mice

NU-9 could prevent early brain damage in Alzheimer’s disease by targeting a newly discovered type of highly-toxic amyloid beta oligomer.

Brain drainage repair offers potential new prevention therapies for Alzheimer’s
12/17/2025

Brain drainage repair offers potential new prevention therapies for Alzheimer’s

Explore new prevention therapies for Alzheimer’s unveiled by UVA researchers linking brain injury to neurodegeneration.

Semaglutide Does Not Treat Alzheimer’s. Could it Prevent Dementia? | ALZFORUM
12/17/2025

Semaglutide Does Not Treat Alzheimer’s. Could it Prevent Dementia? | ALZFORUM

Semaglutide Does Not Treat Alzheimer’s. Could it Prevent Dementia? Go to another part Series - Clinical Trials on Alzheimer's Disease (CTAD) 2025: Quick Links Article Comments References Further Reading Tools Add to my Library Follow News Comments Share How would you like to share? Facebook X Link...

A new test could reveal Alzheimer’s before symptoms appear by tracking how the brain uses sugar.
12/17/2025

A new test could reveal Alzheimer’s before symptoms appear by tracking how the brain uses sugar.

Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the blood called microvesicles, researchers may soon be able to gather brain-specific information with...

Alzheimer's Benefits May Continue After Donanemab Treatment Ends, Data Suggest
12/08/2025

Alzheimer's Benefits May Continue After Donanemab Treatment Ends, Data Suggest

Patients who completed treatment by 12 months fared better than external controls 2 years later

Alzheimer's risk could rise with common condition affecting millions, study finds
12/08/2025

Alzheimer's risk could rise with common condition affecting millions, study finds

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong connection between weight and brain disease progression.

Address

4488 Forest Park, Suite 101
St. Louis, MO
63108

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+13142862683

Website

Alerts

Be the first to know and let us send you an email when WashU Medicine Knight ADRC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram